---
title: "How to Get a Cannabis Licence in Europe… | Cannabivo"
description: "Europe’s cannabis licensing rules remain fragmented in 2026. Here’s what Germany, Spain, Switzerland and others show."
canonical: https://cannabivo.com/news/policy/how-to-get-a-cannabis-licence-in-europe-in-2026-a-country-by-country-policy-guide
language: en
robots: index, follow
og_type: article
type: research-article
language_alternates:
  en: https://cannabivo.com/news/policy/how-to-get-a-cannabis-licence-in-europe-in-2026-a-country-by-country-policy-guide.md
  cs: https://cannabivo.com/cs/novinky/politika/jak-ziskat-licenci-na-konopi-v-evrope-v-roce-2026-pruvodce-politikou-podle-zemi.md
  de: https://cannabivo.com/de/news/politik/wie-man-2026-in-europa-eine-cannabis-lizenz-erhaelt-ein-laender-fuer-laender-politikleitfaden.md
  es: https://cannabivo.com/es/noticias/politica/como-obtener-una-licencia-de-cannabis-en-europa-en-2026-guia-de-politicas-pais-por-pais.md
  fr: https://cannabivo.com/fr/actualites/politique/comment-obtenir-une-licence-de-cannabis-en-europe-en-2026-guide-pays-par-pays-des-politiques.md
  hu: https://cannabivo.com/hu/hirek/szabalyozas/hogyan-szerezzunk-kannabisz-engedelyt-europaban-2026-ban-orszagonkenti-szabalyozasi-utmutato.md
  it: https://cannabivo.com/it/notizie/politica/come-ottenere-una-licenza-per-la-cannabis-in-europa-nel-2026-guida-politica-paese-per-paese.md
  nl: https://cannabivo.com/nl/nieuws/beleid/hoe-krijg-je-in-2026-een-cannabis-vergunning-in-europa-een-land-voor-land-beleidsgids.md
  pl: https://cannabivo.com/pl/aktualnosci/polityka/jak-uzyskac-licencje-na-konopie-w-europie-w-2026-przewodnik-krajowy.md
  pt: https://cannabivo.com/pt/noticias/politica/como-obter-uma-licenca-de-cannabis-na-europa-em-2026-guia-pais-a-pais-de-politicas.md
  ru: https://cannabivo.com/ru/novosti/politika/kak-poluchit-litsenziyu-na-kannabis-v-evrope-v-2026-godu-rukovodstvo-po-kazhdoi-strane.md
  tr: https://cannabivo.com/tr/haberler/politika/2026da-avrupada-kenevir-ruhsati-nasil-alinir-ulke-ulke-politika-rehberi.md
  zh: https://cannabivo.com/zh/news/zhengce/ruhe-zai-2026-nian-huode-ouzhou-de-dama-xuke-zhuguo-zhengce-zhinan.md
  ja: https://cannabivo.com/ja/news/seisaku/2026-nen-ni-yoroppa-de-taima-raisensu-wo-shutoku-suru-houhou-kokubetsu-no-seisaku-gaido.md
  ar: https://cannabivo.com/ar/akhbar/siyasat/kayfa-tahsul-ala-tarkhis-li-al-qnb-fi-awruba-2026-dalil-siyasat-baldan-bi-baldan.md
  ko: https://cannabivo.com/ko/news/jeongchaek/2026nyeon-yureobeseo-daemachyo-myeonheo-reul-badneun-bangsik-gukgabyol-jeongchaek-gaideu.md
  pt-br: https://cannabivo.com/pt-br/noticias/politica/como-obter-uma-licenca-para-cannabis-na-europa-em-2026-guia-de-politicas-pais-a-pais.md
  hi: https://cannabivo.com/hi/samachar/niti/2026-mein-yurop-mein-cannabis-licence-kaise-praapt-karein-desh-dar-desh-neeti-guide.md
generated: 2026-07-31
---

> **Machine-readable Markdown rendering.** This is a Markdown representation of a web page,
> served for AI agents and crawlers as a token-efficient alternative to the full HTML.
> Full interactive HTML version: https://cannabivo.com/news/policy/how-to-get-a-cannabis-licence-in-europe-in-2026-a-country-by-country-policy-guide
> Canonical URL: https://cannabivo.com/news/policy/how-to-get-a-cannabis-licence-in-europe-in-2026-a-country-by-country-policy-guide
> Available languages: en, cs, de, es, fr, hu, it, nl, pl, pt, ru, tr, zh, ja, ar, ko, pt-br, hi

[![Bavarian planning office with cannabis cultivation-association permit papers on the desk](/images/uploads/fa0167a1-aca4-4e37-8670-6e11d9086e5e/news-hero-how-to-get-a-cannabis-licence-in-europe-in-2026-a-country-by-country-policy-guid-1920x1080.jpg)](/images/uploads/fa0167a1-aca4-4e37-8670-6e11d9086e5e/news-hero-how-to-get-a-cannabis-licence-in-europe-in-2026-a-country-by-country-policy-guid-1920x1080.avif "View image full size")

[Policy](/news/policy "Policy")

11 min read

# How to Get a Cannabis Licence in Europe in 2026: A Country-by-Country Policy Guide

![Portrait of Rob Harley, Cannabivo news desk](/images/uploads/5f094d99-3443-4907-8555-2910851fd38a/rob-harley-1920x1920.jpg)By [Rob Harley](/user-profile?u=a65dddce-73db-40b5-8660-fe93612a7384 "View the author's member profile")Published June 14, 2026in [Policy](/news/policy "Policy")

 Europe’s cannabis licensing rules remain fragmented in 2026. Here’s what Germany, Spain, Switzerland and others show.

![Portrait of Rob Harley, Cannabivo news desk](/images/uploads/5f094d99-3443-4907-8555-2910851fd38a/rob-harley-1920x1920.jpg)By [Rob Harley](/user-profile?u=a65dddce-73db-40b5-8660-fe93612a7384 "View the author's member profile")

Rob Harley has reported on cannabis law and the non-profit association movement across Europe for the past decade. He focuses on how regulation actually reaches the members who use cannabis social clubs — the paperwork, the limits, and the slow build of public trust. His work for Cannabivo aims to be accurate, sourced, and free of hype.

[More articles by this author](/news/author/rob-harley "See all articles by this author")Published June 14, 2026in [Policy](/news/policy "Policy")

 In this article1. [Europe still has no single cannabis licence](/news/policy/how-to-get-a-cannabis-licence-in-europe-in-2026-a-country-by-country-policy-guide#europe-still-has-no-single-cannabis-licence "Europe still has no single cannabis licence")
2. [Germany’s licensing fight is now a planning-law fight](/news/policy/how-to-get-a-cannabis-licence-in-europe-in-2026-a-country-by-country-policy-guide#germany-s-licensing-fight-is-now-a-planning-law-fight "Germany’s licensing fight is now a planning-law fight")
3. [Spain’s medical cultivation route stays tightly limited](/news/policy/how-to-get-a-cannabis-licence-in-europe-in-2026-a-country-by-country-policy-guide#spain-s-medical-cultivation-route-stays-tightly-limited "Spain’s medical cultivation route stays tightly limited")
4. [Switzerland uses trials to test regulated access](/news/policy/how-to-get-a-cannabis-licence-in-europe-in-2026-a-country-by-country-policy-guide#switzerland-uses-trials-to-test-regulated-access "Switzerland uses trials to test regulated access")
5. [The EU is still tightening drug controls, not creating a cannabis single market](/news/policy/how-to-get-a-cannabis-licence-in-europe-in-2026-a-country-by-country-policy-guide#the-eu-is-still-tightening-drug-controls-not-creating-a-cannabis-single-market "The EU is still tightening drug controls, not creating a cannabis single market")
6. [What applicants should look for in each country](/news/policy/how-to-get-a-cannabis-licence-in-europe-in-2026-a-country-by-country-policy-guide#what-applicants-should-look-for-in-each-country "What applicants should look for in each country")
7. [Europe’s licensing map is a moving target](/news/policy/how-to-get-a-cannabis-licence-in-europe-in-2026-a-country-by-country-policy-guide#europe-s-licensing-map-is-a-moving-target "Europe’s licensing map is a moving target")

Anyone asking how to get a cannabis licence in Europe in 2026 quickly runs into the same answer: there is no single European licence to apply for. The continent remains a patchwork of national rules, with medical cultivation, club structures, pilot schemes and enforcement priorities all governed differently from one country to the next. That fragmentation is exactly why licensing questions now sit at the centre of both market expansion and legal conflict — from Spain’s tightly limited cultivation authorisations to Germany’s contested club approvals and [Switzerland](/switzerland "13 Cannabis Social Clubs in Switzerland (2026)")’s controlled trials.

## Europe still has no single cannabis licence

The first thing to understand is that **Europe does not offer one unified cannabis licensing pathway**. A 2026 industry guide says regulation remains a patchwork of national rules, with no EU-level legalization and no unified medical prescribing pathway. In practice, that means the answer to “how do I get a cannabis licence?” depends entirely on the country, the activity, and whether the state treats the operation as medical cultivation, a social-club model, or a tightly controlled research pilot [European Cannabis Regulations by Country](https://cannabis-europa.com/insights/european-cannabis-regulations-2026/ "European Cannabis Regulations by Country").

That fragmentation matters because Europe’s cannabis debate is no longer only about access. It is also about licensing capacity, planning law, public-health controls and the administrative bottlenecks that can make a reform exist on paper without becoming usable in practice. The German experience shows how quickly a legal opening can turn into a battle over permits, buildings and municipal enforcement, while Spain and Switzerland illustrate how limited authorisations and pilot schemes can shape the market in different ways.

What the continent-wide picture means

There is no EU cannabis permit you can file for in Brussels. Applicants must work inside national law, and sometimes inside regional or municipal planning rules as well.

## Germany’s licensing fight is now a planning-law fight

Germany is the clearest example of how licensing can become a legal test of the broader reform. The [Deutscher Hanfverband says it is financing a lawsuit](https://hanfverband.de/hanfverband-und-csc-inntal-verklagen-bayern-wegen-verhinderung-von-anbauvereinigungen "Deutscher Hanfverband says it is financing a lawsuit") brought by CSC Inntal after a refusal of building-law approval, aiming to force a basic clarification of how cultivation associations are classified under Bavarian planning law. The dispute is not about a commercial grow licence in the narrow sense alone; it is about whether the state can effectively block **cultivation associations** through administrative and zoning rules.

That legal conflict sits against a broader German backdrop that remains influential across Europe. Reporting from 2026 describes Germany’s legalisation as a source of continuing scrutiny, with licensing complexity still unresolved and the country now Europe’s biggest legal commercial medical marijuana market [The Guardian on Germany’s legalisation debate](https://www.theguardian.com/society/2026/apr/01/report-germany-cannabis-legalisation-fails-settle-debate "The Guardian on Germany’s legalisation debate"). For businesses and club organisers, the lesson is stark: a national law may open the door, but planning, licensing and local implementation still decide who actually gets through it.

[![Bavarian planning office desk with permit papers tied to cannabis cultivation-association approval.](/images/uploads/0a1998c3-cb43-4653-a67b-56596256ff0b/how-to-get-a-cannabis-licence-in-europe-in-2026-a-country-by-country-policy-guide-bavarian-1920x1080.jpg)](/images/uploads/0a1998c3-cb43-4653-a67b-56596256ff0b/how-to-get-a-cannabis-licence-in-europe-in-2026-a-country-by-country-policy-guide-bavarian-1920x1080.avif "View image full size")

A Bavarian building office is where the licensing fight now sits.Germany’s legal scale and its bottlenecks

2026year the Bavarian lawsuit was filed

2,500pharmacies dispensing cannabis in Germany

211grow clubs approved in Germany

500 million eurosGermany’s reported cannabis industry size

Those figures underline why German licensing matters beyond Germany. When a market reaches the scale described in reporting on pharmacies and approved clubs, questions of who can cultivate, where they can operate and how authorities interpret building law become policy questions for the whole European sector [Benzinga on Germany’s cannabis industry](https://www.benzinga.com/markets/cannabis/25/05/45297889/germanys-cannabis-industry-hits-500-million-euros-2500-pharmacies-now-dispense-211-grow-clubs-approved "Benzinga on Germany’s cannabis industry").

Germany’s cannabis licensing debate in context
| Dimension | What the facts show | Source |
|---|---|---|
| Planning law | CSC Inntal’s case challenges a refusal of building-law approval for an association | [DHV lawsuit report](https://hanfverband.de/hanfverband-und-csc-inntal-verklagen-bayern-wegen-verhinderung-von-anbauvereinigungen "DHV lawsuit report") |
| Market scale | Germany is described as Europe’s biggest legal commercial medical marijuana market | [The Guardian on Germany’s legalisation debate](https://www.theguardian.com/society/2026/apr/01/report-germany-cannabis-legalisation-fails-settle-debate "The Guardian on Germany’s legalisation debate") |
| Operational footprint | 2,500 pharmacies dispensing cannabis and 211 approved grow clubs were reported | [Germany’s cannabis industry report](https://www.benzinga.com/markets/cannabis/25/05/45297889/germanys-cannabis-industry-hits-500-million-euros-2500-pharmacies-now-dispense-211-grow-clubs-approved "Germany’s cannabis industry report") |

## Spain’s medical cultivation route stays tightly limited

Spain’s model is narrower and more gatekept. Business of Cannabis reported that [Taima Growth became Spain’s fourth AEMPS-licensed medical cannabis cultivator](https://businessofcannabis.com/taima-growth-becomes-spains-fourth-aemps-licensed-medical-cannabis-cultivator/ "Taima Growth became Spain’s fourth AEMPS-licensed medical cannabis cultivator"), which is a useful reminder that authorisation in Spain is not broad-based but highly selective. Being one of only four companies authorised by the medicines regulator tells you more than a dozen policy papers could: the route exists, but it is constrained.

For applicants, that means the Spanish question is not simply whether cultivation is legal, but whether the medicines regulator will grant one of a very limited number of licences, and whether the business is intended to serve regulated medical supply and export markets rather than a wider domestic commercial field. In a country-by-country guide, Spain therefore belongs in the category of **narrow medical cultivation authorisations**, not open commercial licensing.

[![Institutional office scene with medical cannabis application folders at a Spanish regulator setting.](/images/uploads/41630bff-65bc-4d27-9009-d0729bfdc2df/how-to-get-a-cannabis-licence-in-europe-in-2026-a-country-by-country-policy-guide-spanish-1920x1080.jpg)](/images/uploads/41630bff-65bc-4d27-9009-d0729bfdc2df/how-to-get-a-cannabis-licence-in-europe-in-2026-a-country-by-country-policy-guide-spanish-1920x1080.avif "View image full size")

Spain’s route runs through a medicines regulator, not a general market licence.Why Spain matters to licence seekers

Spain shows how a country can license medical cultivation without creating a broad commercial market. The decisive filter is regulatory authorisation, not retail expansion.

## Switzerland uses trials to test regulated access

Switzerland follows a different logic again. Forbes reported in March 2026 that the country’s cannabis experiment had yielded positive results after three years, and that controlled cannabis pilot projects had expanded in several places to test regulated sales and the public-health effects of legal access [Forbes on Switzerland’s cannabis experiment](https://www.forbes.com/sites/dariosabaghi/2026/03/19/swiss-cannabis-experiment-yields-positive-results-after-three-years/ "Forbes on Switzerland’s cannabis experiment").

For anyone asking how to get a cannabis licence in Europe, Switzerland demonstrates that a licence may be less about entering a commercial market and more about participating in a controlled experiment. The model is useful because it separates the policy question from the retail one: the state can authorise limited projects to gather evidence before deciding whether broader regulation is justified. That makes Switzerland important not because it has answered the licensing question once and for all, but because it uses licensing as a tool of policy testing.

How three European models differ at the licensing stage
| Country | Main licensing route in the facts | What that means in practice | Source |
|---|---|---|---|
| Germany | Cultivation-association approvals and medical-market licences | Applicants face legal and planning-law hurdles, including building approval | [DHV lawsuit report](https://hanfverband.de/hanfverband-und-csc-inntal-verklagen-bayern-wegen-verhinderung-von-anbauvereinigungen "DHV lawsuit report") |
| Spain | AEMPS medical-cannabis cultivation authorisation | Only a very small number of companies are authorised | [Taima Growth report](https://businessofcannabis.com/taima-growth-becomes-spains-fourth-aemps-licensed-medical-cannabis-cultivator/ "Taima Growth report") |
| Switzerland | Controlled pilot projects | Licensing is used to test regulated sales and public-health effects | [Forbes on Switzerland’s experiment](https://www.forbes.com/sites/dariosabaghi/2026/03/19/swiss-cannabis-experiment-yields-positive-results-after-three-years/ "Forbes on Switzerland’s experiment") |

## The EU is still tightening drug controls, not creating a cannabis single market

The licensing environment is also being shaped by the wider EU drugs agenda. The 2026 EUDA report says Europe’s drug market is becoming more complex, with stronger cannabis products among the substances increasing health risks, while the European Union Drugs Agency and the European Commission frame the market as stronger, more diverse and harder to control [EUDA’s 2026 warning](https://www.euronews.com/my-europe/2026/06/09/new-health-risks-emerge-as-europes-drug-market-grows-more-complex-eu-agency-warns "EUDA’s 2026 warning").

That broader caution matters because it sets the political temperature around licensing. Europe is not moving toward a relaxed continent-wide cannabis regime; if anything, the institutional direction is toward more scrutiny of drug markets, more concern about potency, and stronger enforcement cooperation. The Council’s new action plan against drug trafficking and the European Parliament’s work on drug precursors both point in that direction [Council action plan](https://www.consilium.europa.eu/en/press/press-releases/2026/06/04/council-pushes-ahead-with-implementation-of-the-new-eu-action-plan-against-drug-trafficking/pdf/ "Council action plan"), [Parliament on drug precursors](https://www.europarl.europa.eu/legislative-train/carriage/new-rules-on-drug-precursors/report?sid=10101 "Parliament on drug precursors").

[![European policy briefing table with drugs reports and press backdrop in Brussels.](/images/uploads/6f8c1497-0219-4100-9269-a605872658a6/how-to-get-a-cannabis-licence-in-europe-in-2026-a-country-by-country-policy-guide-eu-bruss-1920x1080.jpg)](/images/uploads/6f8c1497-0219-4100-9269-a605872658a6/how-to-get-a-cannabis-licence-in-europe-in-2026-a-country-by-country-policy-guide-eu-bruss-1920x1080.avif "View image full size")

European institutions are tightening controls even as national models diverge.> Europe’s drug market is becoming stronger, more diverse and harder to control.
>
> EU Drugs Agency and European Commission, 2026

## What applicants should look for in each country

Because there is no single licence, applicants need to read each jurisdiction on its own terms. In practical terms, the route depends on whether the country offers a medical-cultivation authorisation, a club-based model, a pilot project, or a restrictive planning regime. The key question is not only whether cannabis is legal in some form, but which authority issues the permit and what legal barrier stands between the applicant and the licence.

1. Identify the legal category first: medical cultivation, social club, pilot project or another regulated channel.
2. Check which authority issues the approval: medicines regulator, municipal body, planning office or another national agency.
3. Read the local enforcement layer as carefully as the statute, because building law and zoning may decide the outcome.
4. Assume the national framework is only the start; in several countries the practical licence path is narrower than the headline reform suggests.
5. Treat EU-level developments as context, not as a substitute for domestic authorisation.

That last point is especially important for people comparing markets. Europe’s cannabis policy environment is moving, but the movement is uneven. Germany’s legalisation has created the continent’s most visible licensing dispute; Spain’s authorisations remain few; Switzerland uses trials to learn rather than to liberalise wholesale. Together they show that “getting a licence” in Europe means navigating a country-specific route, not choosing from one shared menu.

Common questions about cannabis licensing in Europe

Is there one Europe-wide cannabis licence?No. The 2026 facts describe Europe as a patchwork of national rules, with no EU-level legalization and no unified medical prescribing pathway.

Which country in the facts shows the most active licensing dispute?Germany. The DHV and CSC Inntal are challenging a Bavarian refusal of building-law approval for a cultivation association.

How limited is Spain’s medical cultivation route?Very limited. The facts say Taima Growth became only Spain’s fourth AEMPS-licensed medical cannabis cultivator.

What does Switzerland use licensing for?Controlled pilot projects that test regulated sales and the public-health effects of legal access.

## Europe’s licensing map is a moving target

The most useful way to read Europe’s cannabis licence landscape in 2026 is as a moving target rather than a settled system. On one side are national experiments and tightly defined authorisations. On the other are governments and EU bodies that are increasingly attentive to potency, trafficking and public-health risk. That combination makes licensing both more important and more contentious: the permit is no longer a bureaucratic detail, but the point where legal theory becomes real-world access.

Key takeaways

- There is no single EU cannabis licence; the rules remain national and fragmented.
- Germany shows how licensing can run into planning-law and building-permit disputes.
- Spain’s medical cultivation route exists but remains highly limited and selective.
- Switzerland uses controlled pilot projects to test regulated access rather than opening a broad market.
- EU institutions are tightening drug-control policy even as national cannabis models continue to diverge.

For 2026, the answer to how to get a cannabis licence in Europe is less a single procedure than a map of different regulatory systems. Germany, Spain and Switzerland each point to a different route, a different authority and a different political logic. Anyone trying to enter the market has to start with the country — and often with local planning rules — because there is still no European shortcut.

## Sources

1. [European Cannabis Regulations by Country: The 2026 Business Guide (cannabis-europa.com)](https://cannabis-europa.com/insights/european-cannabis-regulations-2026/ "Open source in a new tab: https://cannabis-europa.com/insights/european-cannabis-regulations-2026/")
2. [Hanfverband und CSC Inntal verklagen Bayern wegen Verhinderung von Anbauvereinigungen (hanfverband.de)](https://hanfverband.de/hanfverband-und-csc-inntal-verklagen-bayern-wegen-verhinderung-von-anbauvereinigungen "Open source in a new tab: https://hanfverband.de/hanfverband-und-csc-inntal-verklagen-bayern-wegen-verhinderung-von-anbauvereinigungen")
3. [High times or low blows? Experts fail to clear air over German drug legalisation | Cannabis (theguardian.com)](https://www.theguardian.com/society/2026/apr/01/report-germany-cannabis-legalisation-fails-settle-debate "Open source in a new tab: https://www.theguardian.com/society/2026/apr/01/report-germany-cannabis-legalisation-fails-settle-debate")
4. [Germany's Cannabis Industry Hits 500 Million Euros: 2,500 Pharmacies Now Dispense, 211 Grow Clubs Approve (benzinga.com)](https://www.benzinga.com/markets/cannabis/25/05/45297889/germanys-cannabis-industry-hits-500-million-euros-2500-pharmacies-now-dispense-211-grow-clubs-approved "Open source in a new tab: https://www.benzinga.com/markets/cannabis/25/05/45297889/germanys-cannabis-industry-hits-500-million-euros-2500-pharmacies-now-dispense-211-grow-clubs-approved")
5. [Taima Growth Becomes Spain’s Fourth AEMPS-Licensed Medical Cannabis Cultivator (businessofcannabis.com)](https://businessofcannabis.com/taima-growth-becomes-spains-fourth-aemps-licensed-medical-cannabis-cultivator/ "Open source in a new tab: https://businessofcannabis.com/taima-growth-becomes-spains-fourth-aemps-licensed-medical-cannabis-cultivator/")
6. [Swiss Cannabis Experiment Yields Positive Results After 3 Years (forbes.com)](https://www.forbes.com/sites/dariosabaghi/2026/03/19/swiss-cannabis-experiment-yields-positive-results-after-three-years/ "Open source in a new tab: https://www.forbes.com/sites/dariosabaghi/2026/03/19/swiss-cannabis-experiment-yields-positive-results-after-three-years/")
7. [New health risks emerge as Europe’s drug market grows more complex, EU agency warns (euronews.com)](https://www.euronews.com/my-europe/2026/06/09/new-health-risks-emerge-as-europes-drug-market-grows-more-complex-eu-agency-warns "Open source in a new tab: https://www.euronews.com/my-europe/2026/06/09/new-health-risks-emerge-as-europes-drug-market-grows-more-complex-eu-agency-warns")
8. [Council pushes ahead with implementation of the new EU action plan against drug trafficking (consilium.europa.eu)](https://www.consilium.europa.eu/en/press/press-releases/2026/06/04/council-pushes-ahead-with-implementation-of-the-new-eu-action-plan-against-drug-trafficking/pdf/ "Open source in a new tab: https://www.consilium.europa.eu/en/press/press-releases/2026/06/04/council-pushes-ahead-with-implementation-of-the-new-eu-action-plan-against-drug-trafficking/pdf/")
9. [03 2026 | A new era for European Defence and Security | New rules on drug precursors (europarl.europa.eu)](https://www.europarl.europa.eu/legislative-train/carriage/new-rules-on-drug-precursors/report?sid=10101 "Open source in a new tab: https://www.europarl.europa.eu/legislative-train/carriage/new-rules-on-drug-precursors/report?sid=10101")